Go to the main content area
:::
Sign in
Newsletter
Site Map

News
Database
Startup Ecosystem
Investment Deals
Startups
Investors
Research
Events
About US

Database

Startups

VITNOVO, INC.

VITNOVO, INC.

Update：2026/03/10
Industries
Health Care Diabetes Oncology Pharmaceutical
Add to Favorites Edit
About
Financials
Patent
News
Main Industry
Health Care
Founded Year
2014
Unified Business No.
24762324
Status
Closed
Number of Employees
0
Total Paid-in Capital
0 (NT$)
Location of Company
Taiwan , Taipei City
Website
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.

Similar Companies

ASCLEPIUMM TAIWAN CO., LTD.

ASCLEPIUMM TAIWAN CO., LTD.

1. ASP5006
2. ASP4755
Health Care Biotechnology Pharmaceutical
TAIWANJ PHARMACEUTICALS, CO., LTD.

TAIWANJ PHARMACEUTICALS, CO., LTD.

drug research and development and mainly for chronic inflammation related diseases.
Health Care Biotechnology Pharmaceutical
Pharmasaga Company Limited

Pharmasaga Company Limited

Currently, Pharmasaga has two Pdia4 inhibitors, PS-001 and PS-002, for type 2 diabetes (T2D) and type 1 diabetes (T1D), respectively. Their pre-clinical studies were completed in 2021.
US FDA approved the application of investigation drug (IND), PS-001. W
Health Care Biotechnology Diabetes Medical Pharmaceutical
UWELL BIOPHARMA INC.

UWELL BIOPHARMA INC.

Our therapy involves genetically modifying a patient’s T cells outside the patient’s body, transforming the T cells to express chimeric antigen receptors (CARs), and then reinfusing the engineered T cells back into the patient.
Health Care Biotechnology Clinical Trials Oncology Pharmaceutical Therapeutics
:::